Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Pathophysiological Study of the Postprandial Human Liver
NCT03849235Completed
- Sponsor
- Rigshospitalet
- Start
- Mar 2019
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Rigshospitalet. Primary endpoint: Postprandial phosphoproteomic changes in liver tissue at 60 months. Started Mar 2019; status: completed.
Beyond the preview
Go deeper on NCT03849235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849235.